ArticleFuture oncology (London, England)2024

CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.

Charles D Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.